FDA recommends accelerating Abeona’s gene therapy program – Crain’s Cleveland Business
|
FDA recommends accelerating Abeona's gene therapy program
Crain’s Cleveland Business Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, announced this week that the U.S. Food and Drug Administration has recommended accelerating its gene therapy program into a Phase 3 trial. Abeona, which has offices in Cleveland, … Abeona set to fly into Phase 3 after FDA chat |
